Oliver Schacht is the founder of OpGen. OpGen has raised $500M in total funding. Latest round: Growth. Backed by David Lazar.
Oliver Schacht is a biotechnology executive known for his leadership at OpGen, a company battling antimicrobial resistance. He has previously led three publicly traded companies, including Epigenomics and Curetis, for a combined 16 years. Schacht has raised approximately $500 million across various funding rounds and has experience with three IPOs on major exchanges, including Nasdaq.
Full founder directory · Investor directory · Company funding database · Fundraising library